Semnur Pharmaceuticals, Inc. (SMNR): Cash & Equivalents
$20.0K
As of 2025-12-31
$39.0K
As of 2026-06-30
-71.0%
3-year compound annual growth
| Period ended | Cash & Equivalents | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $20.0K | +66.7% | 2026-02-27, Balance as of period end |
| 2024-12-31 | $12.0K | -94.1% | 2026-02-27, Balance as of period end |
| 2023-12-31 | $204.5K | -75.1% | 2024-04-01, Balance as of period end |
| 2022-12-31 | $819.7K | n/a | 2024-04-01, Balance as of period end |
Cash & Equivalents at similar companies
| Company | Year ended | Cash & Equivalents | Change YoY |
|---|---|---|---|
| Semnur Pharmaceuticals, Inc. (SMNR) | 2025-12-31 | $20.0K | +66.7% |
| NeuroSense Therapeutics Ltd. (NRSN) | 2025-12-31 | $166.0K | -95.1% |
| Alzamend Neuro, Inc. (ALZN) | 2026-04-30 | $710.7K | -82.0% |
| Inhibitor Therapeutics, Inc. (INTI) | 2025-12-31 | $2.38M | -57.6% |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | $1.11M | -27.9% |
| Provectus Biopharmaceuticals, Inc. (PVCT) | 2025-12-31 | $251.3K | -18.3% |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | $2.18M | -33.7% |
| Artelo Biosciences, Inc. (ARTL) | 2025-12-31 | $600.0K | n/a |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | $2.18M | -59.8% |
Compare SMNR, NRSN, ALZN, INTI side by side · Screen every company in Pharmaceutical Preparations ↗